1-1437053-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022834.5(VWA1):c.200G>A(p.Gly67Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000348 in 1,611,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
VWA1
NM_022834.5 missense
NM_022834.5 missense
Scores
4
5
10
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
VWA1 (HGNC:30910): (von Willebrand factor A domain containing 1) VWA1 belongs to the von Willebrand factor (VWF; MIM 613160) A (VWFA) domain superfamily of extracellular matrix proteins and appears to play a role in cartilage structure and function (Fitzgerald et al., 2002 [PubMed 12062410]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.40455917).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWA1 | NM_022834.5 | c.200G>A | p.Gly67Asp | missense_variant | 2/3 | ENST00000476993.2 | NP_073745.2 | |
VWA1 | NM_199121.3 | c.74-269G>A | intron_variant | NP_954572.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA1 | ENST00000476993.2 | c.200G>A | p.Gly67Asp | missense_variant | 2/3 | 1 | NM_022834.5 | ENSP00000417185 | P1 | |
VWA1 | ENST00000495558.1 | c.95G>A | p.Gly32Asp | missense_variant | 2/2 | 2 | ENSP00000463643 | |||
VWA1 | ENST00000471398.1 | c.320G>A | p.Gly107Asp | missense_variant | 2/2 | 3 | ENSP00000464343 | |||
VWA1 | ENST00000338660.5 | c.74-269G>A | intron_variant | 2 | ENSP00000423404 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152246Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
11
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000118 AC: 29AN: 246550Hom.: 0 AF XY: 0.000142 AC XY: 19AN XY: 134034
GnomAD3 exomes
AF:
AC:
29
AN:
246550
Hom.:
AF XY:
AC XY:
19
AN XY:
134034
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1458826Hom.: 0 Cov.: 31 AF XY: 0.0000331 AC XY: 24AN XY: 725576
GnomAD4 exome
AF:
AC:
45
AN:
1458826
Hom.:
Cov.:
31
AF XY:
AC XY:
24
AN XY:
725576
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74502
GnomAD4 genome
AF:
AC:
11
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
10
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.200G>A (p.G67D) alteration is located in exon 2 (coding exon 2) of the VWA1 gene. This alteration results from a G to A substitution at nucleotide position 200, causing the glycine (G) at amino acid position 67 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
.;D;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;.
REVEL
Uncertain
Sift
Benign
.;D;.
Sift4G
Benign
T;D;D
Polyphen
0.25
.;B;.
Vest4
0.42
MutPred
0.72
.;Gain of solvent accessibility (P = 0.0648);.;
MVP
MPC
0.13
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at